This inventor holds 2 USPTO granted patents. Top assignee: William Marsh Rice University. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Innovations of Eugene Zubarev
Introduction
Eugene Zubarev is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of therapeutic compositions and nanoparticle technology. With a total of 2 patents, his work focuses on innovative methods for drug delivery and synthesis of nanoparticles.
Latest Patents
One of his latest patents is titled "Therapeutic compositions and methods for delivery of active agents cleavably linked to nanoparticles." This invention involves therapeutic compositions that include an active agent, such as paclitaxel, and a nanoparticle, like a gold nanoparticle. The active agent is covalently linked to the nanoparticle through a cleavable linker, which allows for effective treatment methods.
Another significant patent is "High-yield synthesis of gold nanorods with optical absorption at wavelengths greater than 1000nm using hydroquinone." This invention provides improved methods for preparing cetyltrimethylammonium bromide-capped gold nanoparticles using hydroquinone as a reducing agent. The process involves creating a seed solution and an aqueous growth solution to produce high-quality nanoparticles.
Career Highlights
Eugene Zubarev is affiliated with William Marsh Rice University, where he conducts research and develops his innovative ideas. His work has garnered attention in the scientific community for its potential applications in medicine and materials science.
Collaborations
Eugene has collaborated with notable colleagues, including Jacob J Gibson and Leonid Vigderman. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Eugene Zubarev's contributions to the field of nanoparticle technology and therapeutic compositions highlight his innovative spirit and dedication to advancing science. His patents reflect a commitment to improving drug delivery methods and enhancing the capabilities of nanoparticles.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
